Fig. 1From: Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trialCryoprecipitate transfusion attenuates fibrinolysis. A PAI-1, B FXIII and C plasmin activity levels were measured using chromogenic assays in plasma samples pre- and post-cryoprecipitate (cryo) and fibrinogen concentrate (Fg-C) transfusion. Grey dotted lines indicate the mean value for 16 healthy volunteers. **pā<ā0.01Back to article page